Dr. Corey Casper is the Chief Executive Officer at the Access for Advanced Health Institute (AAHI), where he oversees a portfolio of vaccines, therapeutics, and diagnostics that provide comprehensive solutions to global health problems. These include immune-enhancing adjuvant formulations that enable strong, safe and durable vaccines, a novel RNA vaccine platform for the prevention of pandemic / emerging viruses, and products for the treatment and prevention of cancer in low- and middle-income countries.

Dr. Casper received his medical degree from Cornell University, completed Residency in Internal Medicine at the University of California – San Francisco and Fellowship in Infectious Disease at the University of Washington, where he also earned a Masters of Public Health. A committed educator and clinician, Dr. Casper is Clinical Professor of Medicine and Global Health at the University of Washington and an Affiliate Professor in the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center.